F-group (family)
284.2.1.1 Glyco_hydro_18
Ligands and drugs
194
Member domains
96
with ligand contacts (≤ 4 Å)
49.5% of members
93
with DrugDomain annotations
47.9% of members
59
with a DrugBank compound
30.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 284.2.1.1 belongs to X-group 284 FKBP-like, which binds 9.3 ligand superclasses per 20 proteins, broader than 84% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 22 |
| DB18065 | QGB | 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine | 6 |
| DB04404 | AMI | Allosamizoline | 5 |
| DB03747 | NGT | N-Acetyl-glucosamine thiazoline | 4 |
| DB03539 | ALI | 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose | 2 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 19 |
| MGmetal | MAGNESIUM ION | 9 |
| DW0 | 1,1'-PROPANE-1,3-DIYLBIS(3,7-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE) | 7 |
| AMI | ALLOSAMIZOLINE | 6 |
| CX9 | 3,7-DIMETHYL-1-[3-(3-METHYL-2,6-DIOXO-9H-PURIN-1-YL)PROPYL]PURINE-2,6-DIONE | 6 |
| QGB | 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-4H-1,2,4-triazol-3-amine | 6 |
| NGT | 3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL | 4 |
| SN5 | 2-deoxy-2-(ethanethioylamino)-beta-D-glucopyranose | 3 |
| 3RM | 5-{4-[2-(4-bromophenoxy)ethyl]piperazin-1-yl}-4H-1,2,4-triazol-3-amine | 2 |
| 58Y | (2R,3aR,5R,6R,7R,7aR)-5-(hydroxymethyl)-2-methylhexahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol | 2 |
| 613 | 4-(4-chlorophenyl)piperazine-1-carboximidamide | 2 |
| 7U8 | methyl 4-[5,6-bis(chloranyl)-1H-indol-3-yl]-3-(5-chloranyl-1H-indol-3-yl)-1H-pyrrole-2-carboxylate | 2 |
| ALI | METHYL N-ACETYL ALLOSAMINE | 2 |
| BV0 | 6-azanyl-11-methyl-2-oxidanylidene-7-[[(2R)-oxolan-2-yl]methyl]-N-(pyridin-3-ylmethyl)-1,9-diaza-7-azoniatricyclo[8.4.0.0^{3,8}]tetradeca-3(8),4,6,9,11,13-hexaene-5-carboxamide | 2 |
| CAmetal | CALCIUM ION | 2 |
| NAmetal | SODIUM ION | 2 |
| RM8 | 2-methyl-3-{[4-(pyridin-2-yl)piperazin-1-yl]methyl}-1H-indole | 2 |
| TLA | L(+)-TARTARIC ACID | 2 |
| 95K | 1-(5-azanyl-4~{H}-1,2,4-triazol-3-yl)-~{N}-[2-(4-bromophenyl)ethyl]-~{N}-(2-methylpropyl)piperidin-4-amine | 1 |
| 95N | 1-(3-azanyl-1~{H}-1,2,4-triazol-5-yl)-~{N}-[2-(4-bromophenyl)ethyl]-~{N}-methyl-piperidin-4-amine | 1 |